MYLES, DAVID C.,KUSHNER, PETER J.,HARMON, CYRUS L.
申请号：
CA3000410
公开号：
CA3000410A1
申请日:
2016.09.29
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, rotamer, N-oxide and/or substituted derivative or, optionally in a pharmaceutical composition, for the modulation of disorders mediated by estrogen, or other disorders as more fully described herein.
